COMMUNIQUÉS West-GlobeNewswire

Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours

20/08/2018 - 08:00

PRESS RELEASE Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours Study of IMCnyeso in NSCLC, Bladder Cancer, Melanoma and Synovial Sarcoma is the first in GSK collaboration (Oxford, UK [...]

Sensorion Receives European Authorization to Initiate SENS-401 Phase 2 Trial in Sudden Sensorineural Hearing Loss

20/08/2018 - 07:30

Sensorion’s 2nd European Voluntary Harmonization Procedure Application Approval International Multicenter Phase 2 with SENS-401 for Treating Sudden Sensorineuronal Hearing Loss in Adults to Start MONTPELLIER, France, [...]

Assure Holdings Reports First Quarter 2018 Financial Results

18/08/2018 - 02:30

– Revenue Increases by 86% to $5.7 Million, Net Income up 30% to $3.0 Million – – Management to Discuss First Quarter Results via Conference Call on Monday, August 20, 2018, at 11:30 A.M. Eastern Time – DENVER, Aug. 17 [...]

Coherus BioSciences Announces New Employment Inducement Grants

17/08/2018 - 23:30

REDWOOD CITY, Calif., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective August 14, 2018, the company’s board of directors granted 3 new employees options to [...]

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

17/08/2018 - 23:15

SANTA BARBARA, Calif., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on August 16, 2018, the Compensation Committee of the [...]

Pain Therapeutics Announces Closing of $11.3 Million Registered Direct Offering

17/08/2018 - 23:15

AUSTIN, Texas, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced the closing of its previously announced registered direct offering of 8,860,778 [...]

Kalytera Announces Further Payments in Shares under Payments Agreements with Salzman Group

17/08/2018 - 23:09

SAN FRANCISCO and TEL AVIV, Israel, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the " Company " or " Kalytera ") today announced that the Company has elected to [...]

CORRECTION - Agility Health Announces Private Placement, Engages Frontier Flex Marketing and Grants Stock Options

17/08/2018 - 22:23

Not for distribution to United States Newswire Services or for dissemination in the United States HAMILTON, Ontario, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Please note that, in a press release issued under the same headline [...]

BioSig Technologies Closes Private Placement

17/08/2018 - 20:30

Company Receives Additional Capital for Commercialization Efforts Santa Monica, CA, Aug. 17, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical [...]

Syneos Health to Present at the 2018 Baird Global Healthcare Conference

17/08/2018 - 15:57

RALEIGH, N.C., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract [...]

BioStem Technologies, Inc. Completes 2016, 2017 Audit of Financial Statements

17/08/2018 - 15:30

Pompano Beach, FL., Aug. 17, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM), a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and [...]

Golden Leaf Holdings Announces Acquisition of Combined Cultivation, Production and Retail License in California

17/08/2018 - 15:08

PORTLAND, Ore., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized [...]

American Pain Association President Selects Tree of Knowledge as CBD Supplier -- CFN Media

17/08/2018 - 15:00

SEATTLE, Aug. 17, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]

Welldoc® to Highlight Adoption of Digital Therapeutics for Improving Diabetes Care with Five Poster Presentations at AADE 2018 Annual Meeting

17/08/2018 - 15:00

Malinda Peeples, RN, MS, CDE, Welldoc’s Vice President of Clinical Services, Programs and Research Recognized Today with AADE Allene Van Son Distinguished Service Award BALTIMORE, Aug. 17, 2018 (GLOBE NEWSWIRE) -- [...]

Mateon Therapeutics Receives Notice of Partial Clinical Hold for OX1222 Study

17/08/2018 - 14:50

SOUTH SAN FRANCISCO, Calif., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today [...]

Navamedic ASA: Invitation to presentation of second quarter 2018

17/08/2018 - 14:42

Navamedic ASA invites you to a presentation of the second quarter 2018 figures. The presentation will take place at Felix Konferansesenter, Aker Brygge, Oslo, Friday 24 August. The presentation will start at 08.00 The [...]

VPR Brands, LP Announces Second Quarter 2018 Results

17/08/2018 - 14:30

FORT LAUDERDALE, FL, Aug. 17, 2018 (GLOBE NEWSWIRE) -- VPR Brands, LP (OTC PINK: VPRB), a market leader specializing in accessories and vaporizers for essential oils, cannabis concentrates and extracts as well as [...]

Endocyte Announces Presentations at the American Chemical Society (ACS) National Meeting & Exposition

17/08/2018 - 14:30

WEST LAFAYETTE, Ind., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that two posters will [...]

Evolus Granted Approval of DWP-450 by Health Canada

17/08/2018 - 14:01

IRVINE, Calif., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced that Health Canada has granted approval of DWP-450 (prabotulinumtoxinA) for the [...]